Literature DB >> 9364984

Ultrasensitive fluorogenic substrates for serine proteases.

S Butenas1, M E DiLorenzo, K G Mann.   

Abstract

Selective, sensitive assays for the quantitation of serine proteases involved in coagulation and fibrinolysis have been developed employing fluorogenic substrates containing a 6-amino-1-naphthalenesulfonamide leaving group (PNS-substrates). Over one hundred substrates were evaluated for hydrolysis by the serine proteases of blood coagulation and fibrinolysis, and substrate structure-efficiency correlations were examined. PNS-substrates which contain Lys in the P1 position are specific for Lys-plasmin and are either not hydrolyzed or hydrolyzed at a relatively low rate by factor Xa, thrombin, or urokinase-type plasminogen activator (uPA). These substrates allow quantitation of Lys-plasmin at concentrations as low as 1 pM. Eighteen of over 90 substrates tested for factor XIa are hydrolyzed by this enzyme at a relatively high rate reaching a k(cat), value of 170 s(-1) and allowing quantitation of factor XIa at 10 fM. Eighteen of almost 90 PNS-substrates tested display high specificity for thrombin, some exceeding that for factor Xa by >10,000-fold and >100-fold for activated protein C (APC). Seven of these substrates have a k(cat) over 100 s(-1) and three of them have a K(M) below 1 microM. They allow the quantitation of thrombin at concentrations as low as 20 fM. For APC, uPA and the factor VIIa/tissue factor complex, quantitation is feasible at 1 pM concentration. For factor Xa and factor VIIa the limits are 0.4 pM and 40 pM respectively. The PNS-substrates presented in this study may be employed for the development of direct and sensitive serine protease assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364984

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

3.  Rivaroxaban delivery and reversal at a venous flow rate.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

4.  The plasma hemostatic proteome: thrombin generation in healthy individuals.

Authors:  K Brummel-Ziedins; C Y Vossen; F R Rosendaal; K Umezaki; K G Mann
Journal:  J Thromb Haemost       Date:  2005-07       Impact factor: 5.824

5.  Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.

Authors:  Laura M Haynes; Beth A Bouchard; Paula B Tracy; Kenneth G Mann
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

6.  Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.

Authors:  Tim J Schuijt; Kamran Bakhtiari; Sirlei Daffre; Kathleen Deponte; Simone J H Wielders; J Arnoud Marquart; Joppe W Hovius; Tom van der Poll; Erol Fikrig; Matthew W Bunce; Rodney M Camire; Gerry A F Nicolaes; Joost C M Meijers; Cornelis van 't Veer
Journal:  Circulation       Date:  2013-07-01       Impact factor: 29.690

7.  Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays.

Authors:  Yideng Liang; Joseph W Jackson; Samuel A Woodle; Stepan S Surov; Leonid A Parunov; Dorothy E Scott; Mark Weinstein; Timothy K Lee; Mikhail V Ovanesov
Journal:  Res Pract Thromb Haemost       Date:  2020-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.